Skip to content
Search

Latest Stories

Olivier Picard named new NPA chair

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.


He owns and operates four pharmacies in the Home Counties and has served as the association’s vice-chair for the past two years.

“It’s an honour to take over as chair from my brilliant predecessor Nick Kaye who has worked so energetically on behalf of NPA members and will undoubtedly continue to do so. His are big shoes to fill, but I will wear them with pride. I’ll keep the interests of NPA members at the heart of everything I do,” said Picard.

“As I look forward to the challenges ahead, I’m pleased to be surrounded by high calibre board colleagues and an impressive staff team.

Having trained as a pharmacist in France, Picard has spent most of his working life in the UK, working in community pharmacy for almost 20 years.

He was an area manager in Moss Pharmacy and established his own pharmacy business in 2006.

He has worked with the PSNC on rural pharmacy matters. He has been active promoting pharmacy on local and national BBC stations.

“I will keep asking, why are we here and how can we make things better, together? For me the answer to that question is because we care, because we can see a system that can be better, because we believe that change is possible, and because we know that the people we serve – our patients, our communities and our colleagues deserve nothing less.”

Sukhi Basra, who has served her central London community for over 25 years as owner of CliniChem Pharmacy in Victoria, has been named as vice-chair.

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chairSukhi Basra

She said: “I am a keen advocate for raising the profile of community pharmacy, which is a humble profession that is frequently overlooked as a solution for important healthcare challenges.

“We are clinicians and specialists in the use of medicines, not shop keepers.

“As the NPA’s first female Vice Chair, it’s wonderful to be in a leadership position on a board with the highest proportion of female representation in the NPA’s long history.”

In his term as chair, Kaye oversaw a crucial period for the sector which included campaigning for the new pharmacy contract that was eventually announced in March.

“It has been the professional privilege of my career to chair an organisation I care so deeply about. I want to thank the amazing people that work within the organisation and do so much behind the scenes, and my fellow board colleagues that spend time away from their businesses, family and friends and sacrifice a lot to represent us all,” said Kaye.

“In the last two years, together, we have achieved a lot – including a sustained media campaign raising the profile of members, our struggles and showcasing community pharmacy as whole, and I do believe this moved the number positively in the English contract negotiations, whilst also supporting the entire membership across all four nations.

“Plus travelling to Scotland, Wales and Northern Island to see how the NPA uniquely works across these jurisdictions and sharing best practice which benefits us all.

“We as an organisation are for our members from our members - a family of families. This ethos runs through everything we do.”

Joining the NPA board for the period April 2025 to March 2027, alongside existing members, are Dorset pharmacist Mike Hewitson, Dave Thomas from Cardiff and Joanne Wolfe representing NPA members in Northern Ireland.

Hewitson and Basra will serve two years as NPA nominees to Community Pharmacy England.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less